For those bringing innovative treatments to market, change comes fast – yet many of the same obstacles arise again and again.
In March, STAT will convene Breakthrough East, our annual NYC summit focused on advancements in pharmaceutical, medical device, and diagnostic research and development.
We won't ignore the fact that at that point the entire $4 trillion U.S. health care industry will exist in a new political and regulatory reality. But we'll also focus on big questions that have remained unanswered for decades.
Why doesn't developing new treatments get cheaper as science improves?
Why don't results in mice predict what will work in human beings?
Can AI help researchers make better decisions?
What is the right balance for regulators to take between speed and safety?
Your guides on this journey will include STAT's award-winning journalists.
We'll share more details throughout our planning process. But right now you can sign up to attend at a low introductory rate. I hope to see you there.
Matthew Herper X: @matthewherper Editorial Director, Events
No comments